Issue 24, 1999

A β-galactoside phosphoramide mustard prodrug for use in conjunction with gene-directed enzyme prodrug therapy

Abstract

4-(β-D-Galactopyranosyl)benzyl N,N,N′,N′-tetrakis(2-chloroethyl)phosphorodiamidate 1 was facilely biotransformed to the alkylating antitumor agent, N,N,N′,N′-tetrakis(2-chloroethyl) phosphorodiamidic acid, 4, when incubated with E. coli β-galactosidase, and therefore has potential for use in conjunction with gene-directed enzyme prodrug therapy.

Article information

Article type
Paper

Chem. Commun., 1999, 2527-2528

A β-galactoside phosphoramide mustard prodrug for use in conjunction with gene-directed enzyme prodrug therapy

A. K. Ghosh, S. Khan and D. Farquhar, Chem. Commun., 1999, 2527 DOI: 10.1039/A907719G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements